Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Spinomenal Strikes Content Deal with Casino777

Spinomenal, the leading iGaming content provider, has agreed a to new content collaboration with standout casino operator, Casino777. The content will be integrated via Light & Wonder’s OpenGaming™ platform.Players on Casino777 in Belgium and the Netherlands will get instant access to Spinomenal’s meticulously designed games portfolio which is teeming with titles recognised for stunning graphics and engaging in-game features.Some of these top titles now available on Casino777 are WereWolf - The Hunt, Lucky Jack - Lost Jungle, Fairytale Beauties and Athena’s Glory.  Lior Shvartz, CEO

Devyser and Thermo Fisher Scientific collaborate to promote laboratory services to advance pharmaceutical research

Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote laboratory services. The goal is to partner with pharmaceutical companies to support their development projects utilising Devyser’s unique assays in its CLIA-certified laboratory.  The companies will work together to promote the Devyser laboratory services to support and advance research and development for pharmaceutical companies. “We are very excited to enter into this agreement. Being able to support pharmaceutical companies’ development projects to enable new and improved therapies is a

No increase in cancer risk for most patients with reflux disease

Reflux disease manifests as acid regurgitation and heartburn and is a known risk factor for oesophageal cancer. However, a new study published in The BMJ by researchers at Karolinska Institutet now reports that the majority of patients do not have a higher risk of cancer. A large-scale study from three Nordic countries shows that the cancer risk is only elevated in patients whom gastroscopy reveals to have changes in the oesophageal mucosa.“This is a gratifying result since reflux disease is a very common condition and most patients are found to have a completely normal mucus membrane on

Sileon publishes prospectus in connection with the upcoming rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND, RUSSIA, THE UNITED STATES OR ANY OTHER JURISDICTION, WHERE SUCH ACTIONS ARE SUBJECT TO LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER REGARDING ANY SECURITIES IN SILEON AB (PUBL). SEE ALSO THE “IMPORTANT INFORMATION” SECTION BELOW. The board of directors of Sileon AB (publ), ("Sileon" or the "Company"), in connection with the rights issue with pre-emptive rights for existing shareholders

Read original

Cline Scientific's former CEO, Patrik Sundh, returns to the post of CEO after a break

Cline Scientific AB (publ) ("Cline" or the "Company") board has, after discussions with former CEO Patrik Sundh, decided to reinstate him as CEO of the company after Patrik declared himself ready to resume the role.After a successful share issue during the summer, the board of Cline Scientific has carefully analyzed what the business should continue to focus on during the fall in order to reach the goals set for StemCART. The result of this analysis clearly shows a great need to continue the pre-clinical activities in order to build a stronger result base for a future partner. The person

Prospective Episealer® Talus clinical study fully recruited

Episurf Medical (Nasdaq: EPIS B) today announces that all patients have been recruited to a prospective clinical study on the Episealer Talus® implant, led by Prof. Stefano Zaffagnini, from the Rizzoli Orthopaedic Institute in Bologna, Italy, supported by Dr Massimiliano Mosca and Prof. Niek van Dijk. The study will follow 20 patients who received an Episealer Talus® implant as treatment for osteochondral defects in their ankle joint. Episealer® Talus is Episurf Medical’s CE marked implant technology, intended for the treatment of ankle lesions.  “Our technology for ankle lesions is

Spinnova and Renewcell announce cooperation to scale circular fashion

Spinnova, the sustainable textile material company, partners with Swedish textile recycling innovator Renewcell to develop and promote a concept to commercialise and scale textile waste-based fibre. The collaboration is the first of its kind, where textile waste-based fibre can be spun into new fibre without harmful chemicals. The first consumer products from this new textile fibre are estimated to be available by the end of 2024. Award-winning circular innovation companies Spinnova and Renewcell have announced their cooperation to introduce a technology concept for scaling the

NoHo Partners Plc: Managers' transactions (Laine)

NoHo Partners PlcMANAGERS' TRANSACTIONS 13.9.2023 11:00NoHo Partners Plc: Managers' transactions (Laine) ____________________________________________ Person subject to the notification requirementName: Alex LainePosition: Closely associated person (1):Person Discharging Managerial Responsibilities In IssuerName: Timo LainePosition: Member of the BoardIssuer: NoHo Partners OyjLEI: 743700DYZ6R1QNLWQA56Notification type: INITIAL NOTIFICATIONReference number: 37678/4/4 ____________________________________________ Transaction date: 2023-09-12Venue: NASDAQ

Notification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä Corporation

Wärtsilä Corporation, flagging notification, 13 September 2023 at 11:00 EESTNotification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä CorporationBlackRock, Inc. has informed Wärtsilä Corporation that it has crossed below the 5% disclosure limit on total holding in shares and voting rights on 11 September 2023. Following the transaction, BlackRock, Inc. owns 4.95% of Wärtsilä’s shares and voting rights, while its total holding in Wärtsilä Corporation corresponds to 5.03%. Total position of BlackRock, Inc. and its funds subject

Transaction in Own Shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 13 September 2023 REDDE NORTHGATE PLC (“Redde Northgate” or the “Group” or the “Company”)   Transaction in Own Shares   Redde Northgate plc (LSE:REDD) announces that on 12 September 2023 it purchased the following number of its own shares to be held in treasury:   Class of shares :  Ordinary shares of 50p (“shares”)

Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.’s holding in Metso

Metso Corporation’s stock exchange release on September 13, 2023, at 10:30 a.m. EESTMetso Corporation has received a notification, pursuant to Chapter 9, Section 5 and 6 of the Finnish Securities Markets Act, about a change in the shareholding of BlackRock, Inc. On September 11, 2023, BlackRock's holding in Metso’s shares fell below the 5 percent threshold and amounted to 40,968,111 shares or 4.94 percent of total shares and votes. BlackRock's holding through financial instruments in Metso amounted to 1,751,278 shares, which corresponds to 0.21 percent of the total amount of Metso’s

Peak Fear Experiment Seeks Volunteers for Research at a Secret Location in Sweden

Swedish amusement park Liseberg is looking for volunteers for “The Peak Fear Experiment” at a secret location in Sweden. The participants can expect to face their worst fears and explore their own limits of scary entertainment. The experiment, conducted in collaboration with world-leading scientists from Recreational Fear Lab at Aarhus University in Denmark, will take place on October 11th, 2023. Photo: Liseberg/ Is This It Watch the trailer... if you dare...  https://www.youtube.com/watch?v=VI278SmMsZM "If you are over 18 years old, enjoy being frightened, and can be in

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 142- 13 SEPTEMBER 2023 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 112/23 and 113/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

AFRY continues as lead planning partner in the next phase of the Finnish Tampere–Jyväskylä railway

AFRY has been the lead planning partner in The Finnish Transport Infrastructure Agency’s Tampere–Jyväskylä railway planning project since the beginning of 2023. As the project now moves on to the implementation phase, AFRY has been chosen to continue as lead designer.The Tampere–Jyväskylä railway line is one of the main lines of the Finnish railway network. To enable a regular timetable for passenger transportation, increase the capacity of the rail section, reduce travel time, and improve resilience to disruptions, the Finnish Transport Infrastructure Agency has chosen to continue to

ExpreS2ion’s Board, CEO and CFO commit to full exercise of their series TO 8 warrants

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. Hørsholm, Denmark, 13 September 2023 - ExpreS2ion Biotech Holding AB's ("ExpreS2ion" or the "Company") announces that the full Board of Directors, as well as its CEO and CFO, have individually committed to exercise all of their series TO

GARO adapting and increasing organizational efficiency

GARO will conduct an efficiency program with the aim of adapting the organization following the completed relocation of the production and logistics facility. The Group intends to reduce its workforce by about 45 employees, including both white-collar employees and employees under collective contracts, primarily in the GARO Electrification business area.   For more information, please contact:Patrik Andersson, CEO: +46 (0)76 148 44 44Helena Claesson, CFO: +46 (0)70 676 07 50  This information is such information that GARO aktiebolag is obligated to publish in accordance with

No more waste from renovation? Kiilto revolutionizes the global construction industry with an adhesive solution that enables full recyclability of used materials.

Kiilto, a Finnish company with over 100 years of experience in producing world-leading chemical industry solutions, presents a groundbreaking adhesive solution. The new adhesive solution makes, for instance, construction and renovation waste recyclable, and thus helps make the whole built environment more sustainable.Given that buildings use a large part of all consumed energy, causing more than 40 percent of global emissions, and that the demolition waste of buildings accounts for nearly a third of all waste, the climate conversation often revolves around the built environment and

More sustainability measures for commercial forests – Metsä Group to organise an idea competition, Renew Metsä

To find ideas for further developing operations in commercial forests, Metsä Group will organise a competition called Renew Metsä for the owner-members of its parent company Metsäliitto Cooperative. The competition seeks new concrete ideas for boosting the varied use, biodiversity, climate resilience, vitality and water protection of commercial forests while also paying attention to economic considerations. “We at Metsä Group and our owner-members play an important role in the wellbeing of forests across Finland. As a result of our investments, our role will continue to increase. The

Wärtsilä solutions chosen for world’s first methanol fuelled hybrid RoRo vessels

Wärtsilä Corporation, Press Release, 13 September 2023 at 10 am EESTTechnology group Wärtsilä will supply an integrated hybrid propulsion system for two new hybrid RoRo vessels. The ships are being built at the China Merchants Jinling shipyard (Weihai) Co., Ltd for the Swedish shipping company Stena RoRo. The ships will be the world’s first methanol fuelled hybrid RoRo vessels and will operate in the Stena Line Irish Sea system. The combination of new sustainable fuels and electrification is in line with the company’s sustainable operations target. Part of the order was booked by Wärtsilä

Composition of Kojamo plc’s Shareholders’ Nomination Board

Kojamo plc Stock Exchange Release, 13 September 2023 at 10:00 a.m. EESTComposition of Kojamo plc’s Shareholders’ Nomination Board Kojamo plc’s three largest shareholders have nominated the following members to the Shareholders’ Nomination Board: · Christian Fladeland, CIO, Heimstaden AB · Jouko Pölönen, CEO, Ilmarinen Mutual Pension Insurance Company · Risto Murto, CEO, Varma Mutual Pension Insurance Company In addition, the Chairman of Kojamo’s Board of Directors, will serve as the Nomination Board’s expert member. The right to nominate representatives is vested with

Composition of Sitowise's Shareholders' Nomination Board

Sitowise Group Plc, Stock Exchange Release, 13 September 2023 at 10.00 a.m. (EEST) The Annual General Meeting of Sitowise Group Plc decided on 25 April 2023 to establish a Shareholders' Nomination Board. The following members have been appointed to Sitowise Group Plc's Shareholders' Nomination Board: · Mr. Juhana Kallio, Intera Partners, · Ms. Malin Björkmo, Handesbanken Fonder, · Mr. Claes Murander, Lannebo Fonder, and · Mr. Eero Heliövaara, Chair of Sitowise Board of Directors. The Shareholders’ Nomination Board of Sitowise consists of a representative of each of the

BioStock: Cline Scientific ready for the next challenge

During the summer, biotech company Cline Scientific successfully carried out a share issue to raise approximately SEK 6.1 million before expenses. With the new capital, the company can take on the next challenge – to drive the stem cell project StemCART towards clinical studies. BioStock talked to CEO Hanne Evenbratt about the Cline's path forward.Read the interview with Cline Scientific's CEO Hanne Evenbratt at biostock.se: https://www.biostock.se/en/2023/09/cline-scientific-ready-for-the-next-challenge/ This is a press release from BioStock - Connecting Innovation & Capital. https://

Two Brain+ grant applications pass first evaluation gate with unanimous support from evaluators

Copenhagen, Denmark, September 13, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · The EIC Accelerator application of DKK 60 million in grant and equity funding, submitted in late August to support the CST-Home Care product, has passed to the 2[nd] and final evaluation round with unanimous evaluator support · The application for a DKK 4 million CO-PI grant also submitted in August to support the implementation of CST-Therapist Companion in Denmark, has passed the first screening and expanded answers have been submitted · For both grants, as well as for the InnoBooster grant, final

Gedea Biotech granted European Patent for the formulation of its vaginal pHyph tablet for women with vaginal infections

· Further strengthens Gedea Biotech’s broad patent portfolio · pHyph has demonstrated a superior safety profile, a cure rate in line with antibiotics and a lower infection recurrence rate · Additionally, unlike antibiotics, pHyph will not promote antimicrobial resistance    Lund, Sweden, September 13, 2023. Swedish women’s health company Gedea Biotech announced today that the European Patent Office (EPO) has granted the company´s patent application no. 20715885.8 for the formulation of the active ingredient, Glucone-delta lactone (GDL) in pHyph™, the company’s vaginal tablet for

There are no items matching the current filter
There are no more items matching the current filter
Back to top